Sarah Lauren Hughey, MD
Dermatology · Birmingham, ALNPI 1326075425
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $104,862 of the $143,090 with a category attached, or 73.3%. Kyowa Kirin, Inc. accounts for 79.3% of it on its own, with 42 other manufacturers making up the rest. 2025 is the largest year on record at $32,981, 2.2 times the $15,049 reported in 2019. Among dermatology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 946 payments — averaging $151.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kyowa Kirin, Inc.$113K
- Helsinn Therapeutics (U.S.), Inc.$12K
- Bausch Health US, LLC$4K
- AbbVie$3K
- Novartis$1K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$1K
- plus $9K from 37 others
Across 1 payment — averaging $699.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$699
What the payments were for
- Consulting fees$12,5449%
- Speaking & faculty fees$104,86273%
- Travel & lodging$8,7916%
- Food & beverage$16,42311%
- Education$4710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$143,090 in reported general payments places this provider in the 90th percentile of 168 dermatology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bexarotene | 54 | $509,495 |
| Skyrizi PenRisankizumab-Rzaa | 13 | $261,092 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 13 | $93,823 |
| ValchlorMechlorethamine Hcl | 15 | $90,104 |
| PegasysPeginterferon Alfa-2a | 19 | $20,528 |
| Ivermectin | 13 | $4,555 |
| Clobetasol Propionate | 80 | $3,615 |
| Azelaic Acid | 19 | $3,264 |
| Fluorouracil | 34 | $2,836 |
| Ketoconazole | 135 | $2,582 |
| Triamcinolone Acetonide | 106 | $1,627 |
| Metronidazole | 33 | $1,408 |
| Doxycycline Hyclate | 37 | $1,136 |
| Betamethasone Dipropionate | 18 | $1,095 |
| Halobetasol Propionate | 11 | $894 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Birmingham
- James KrellBirmingham$944K
- Julie HarperBirmingham$920K
- Corey HartmanBirmingham$573K
- Boni ElewskiBirmingham$271K
- Tiffany MayoBirmingham$256K
- Kristy CurlBirmingham$158K
- Megan CherryBirmingham$137K
- Ann HillBirmingham$56K
- Lauren GrahamBirmingham$45K
- Stacy HaynesBirmingham$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.